A universal tool for stability predictions of biotherapeutics, vaccines and in vitro diagnostic products.
Ontology highlight
ABSTRACT: It is of particular interest for biopharmaceutical companies developing and distributing fragile biomolecules to warrant the stability and activity of their products during long-term storage and shipment. In accordance with quality by design principles, advanced kinetic modeling (AKM) has been successfully used to predict long-term product shelf-life and relies on data from short-term accelerated stability studies that are used to generate Arrhenius-based kinetic models that can, in turn, be exploited for stability forecasts. The AKM methodology was evaluated through a cross-company perspective on stability modeling for key stability indicating attributes of different types of biotherapeutics, vaccines and biomolecules combined in in vitro diagnostic kits. It is demonstrated that stability
SUBMITTER: Huelsmeyer M
PROVIDER: S-EPMC10284933 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA